KBG Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for KBG.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Chemicals Gewinnwachstum	67.8%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

Aug 06

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Mar 02

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da KBG jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

KOSDAQ:A318000 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	23,204	4,736	556	5,264	N/A
3/31/2024	22,382	5,005	3,539	6,585	N/A
12/31/2023	21,589	4,583	7,246	9,468	N/A
9/30/2023	22,166	3,671	7,464	9,128	N/A
6/30/2023	22,998	3,841	4,454	5,772	N/A
3/31/2023	23,752	2,976	3,685	5,617	N/A
12/31/2022	24,346	3,252	-618	1,670	N/A
9/30/2022	26,897	4,487	-2,563	319	N/A
6/30/2022	27,525	4,054	-296	3,012	N/A
3/31/2022	27,398	4,246	374	3,003	N/A
12/31/2021	27,201	4,004	734	3,094	N/A
9/30/2021	24,530	4,038	2,027	3,564	N/A
6/30/2021	23,138	4,059	1,092	1,884	N/A
3/31/2021	20,765	3,331	100	935	N/A
12/31/2020	19,788	3,123	1,708	2,580	N/A
9/30/2020	19,428	3,051	0	2,533	N/A
6/30/2020	18,408	-1,355	21	2,887	N/A
3/31/2020	19,152	-1,223	266	2,921	N/A
12/31/2019	18,526	-1,405	482	3,053	N/A
9/30/2019	18,348	-1,932	3,256	4,296	N/A
3/31/2019	17,363	2,230	2,643	3,564	N/A
12/31/2018	16,434	2,130	1,144	1,984	N/A
12/31/2017	14,406	1,641	N/A	1,385	N/A
12/31/2016	13,132	1,561	N/A	2,224	N/A
12/31/2015	12,989	1,260	N/A	2,328	N/A
12/31/2014	12,628	897	N/A	1,038	N/A
12/31/2013	15,107	1,410	N/A	1,787	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Insufficient data to determine if A318000's forecast earnings growth is above the savings rate (2.6%).

Ertrag vs. Markt: Insufficient data to determine if A318000's earnings are forecast to grow faster than the KR market

Hohe Wachstumserträge: Insufficient data to determine if A318000's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: Insufficient data to determine if A318000's revenue is forecast to grow faster than the KR market.

Hohe Wachstumseinnahmen: Insufficient data to determine if A318000's revenue is forecast to grow faster than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if A318000's Return on Equity is forecast to be high in 3 years time

KBG Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Investor sentiment deteriorates as stock falls 15%

New minor risk - Share price stability

Investor sentiment improves as stock rises 32%

The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

Investor sentiment deteriorates as stock falls 19%

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

Inaugural dividend of ₩99.50 per share

New major risk - Share price stability

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 28%

Investor sentiment deteriorates as stock falls 18%

New minor risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 57%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 42%

Inaugural dividend of ₩100.00 per share

Third quarter 2022 earnings released: EPS: ₩169 (vs ₩117 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Inaugural dividend of ₩75.00 per share

Third quarter 2021 earnings released: EPS ₩117 (vs ₩121 in 3Q 2020)

Investor sentiment improved over the past week

Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Korea Bio-Gen Co.,Ltd, Annual General Meeting, Mar 26, 2021

The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Investor sentiment improved over the past week

New 90-day high: ₩10,950

New 90-day high: ₩8,390

Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

First Dividend Is ₩50.00 Per Share

Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

New 90-day low: ₩6,880

New 90-day high - ₩7,500

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken